Filing Details
- Accession Number:
- 0001140361-13-012045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-12 16:58:38
- Reporting Period:
- 2013-03-08
- Filing Date:
- 2013-03-12
- Accepted Time:
- 2013-03-12 16:58:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1234710 | Kenneth Abramowitz | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-03-08 | 2,000 | $13.94 | 23,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Reflects the weighted average sale prices of the shares sold. The shares were sold in multiple trades at prices ranging from $13.94 to $13.95 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.